BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 15, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» Grant supports progression of Theolytics’ oncolytic adenovirus THEO-260 into clinic
To read the full story,
subscribe
or
sign in
.
Cancer
Grant supports progression of Theolytics’ oncolytic adenovirus THEO-260 into clinic
Sep. 2, 2024
Theolytics Ltd. has been awarded £2 million (US$2.6 million) from Innovate UK to support the clinical development of its lead candidate.
BioWorld Science
Cancer
Grant
